Tesamorelin 10mg

Description

Tesamorelin Peptide Overview

Tesamorelin is a stabilized synthetic analog of growth hormone-releasing hormone (GHRH). Engineered for greater metabolic stability than native GHRH, it is well studied in research for stimulating the endogenous growth-hormone axis, with particular interest in visceral-adipose metabolism.

GHRH Receptor Activation

Tesamorelin binds GHRH receptors on the anterior pituitary and is studied for promoting the pulsatile release of endogenous growth hormone and downstream IGF-1 in research models.

Visceral Fat Metabolism Research

A distinctive area of tesamorelin research is its studied effect on visceral adipose tissue, making it of interest in metabolic and body-composition research models.

Stabilized GHRH Structure

A modification to the N-terminus increases resistance to enzymatic degradation, giving tesamorelin greater stability than native GHRH — a key focus of its pharmacology research.

Specifications

• CAS Number: 218949-48-5
• Molecular Formula: C221H366N72O67S
• Molar Mass: 5135.9 g/mol
• Class: Stabilized GHRH analog (44-amino-acid peptide)
• Storage: Refrigerate after reconstitution.
• Form: Lyophilized powder in a sterile glass vial.
• Purity: Minimum 99%
• Quantity: 10mg per vial
• Color: White

Important Note: This product is intended solely for in vitro laboratory research by licensed professionals. It is not approved by the FDA for human or animal use and should not be misbranded, misused, or mislabeled as a drug, food, supplement, or cosmetic.

References:

1. Falutz J. et al. – Tesamorelin, a GHRH analog, and visceral adipose tissue – New England Journal of Medicine
2. Tesamorelin and the growth-hormone axis – Clinical Endocrinology
3. Stabilized GHRH analogs – Expert Opinion on Investigational Drugs